{"title":"越南胡志明市慢性阻塞性肺疾病门诊患者的焦虑和抑郁相关因素","authors":"Nhung Quynh Nguyen, Van Ngoc Huynh, Q. To, K. To","doi":"10.4103/WHO-SEAJPH.WHO_SEAJPH_149_21","DOIUrl":null,"url":null,"abstract":"This study investigates the prevalence of and associated factors with depression and anxiety among chronic obstructive pulmonary disease (COPD) outpatients at Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam. A cross-sectional study was conducted between March and May 2020 at the hospital's outpatient department. Those aged ≥18 years, diagnosed with COPD and undergoing COPD treatment, were eligible. The Hospital Anxiety and Depression Scale was used to measure depression and anxiety. Dyspnea was assessed using the modified Medical Research Council (mMRC) dyspnea scale. Among 392 patients, 381 (97%) participated in the study. The number of patients with depression and anxiety was 33.1% and 21.3%, respectively. Compared to men, women were more likely to experience depression (adjusted odds ratio [aOR] = 2.12, 95% confidence interval [CI] = 1.06–4.24) and anxiety (aOR = 4.11, 95% CI = 1.90–8.87). Those not having caregivers were more likely to experience depression (aOR = 3.03, 95% CI = 1.27–7.20) and anxiety (aOR = 3.47, 95% CI = 1.26–9.60). Having mMRC dyspnea scale ≥2 was associated with higher odds of experiencing depression (aOR = 5.94, 95% CI = 3.63–9.72) and anxiety (aOR = 6.78, 95% CI = 3.48–13.18). Those not adhering to medication treatment (aOR = 2.32, 95% CI = 1.15–4.70) and having comorbidity (aOR = 2.02, 95% CI = 1.10–3.73) were more likely to experience anxiety. Routine screening of COPD patients for depression and anxiety is necessary so that early interventions could be provided.","PeriodicalId":37393,"journal":{"name":"WHO South-East Asia journal of public health","volume":"37 1","pages":"95 - 100"},"PeriodicalIF":0.0000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Factors associated with anxiety and depression among chronic obstructive pulmonary disease outpatients in Ho Chi Minh City, Vietnam\",\"authors\":\"Nhung Quynh Nguyen, Van Ngoc Huynh, Q. To, K. To\",\"doi\":\"10.4103/WHO-SEAJPH.WHO_SEAJPH_149_21\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This study investigates the prevalence of and associated factors with depression and anxiety among chronic obstructive pulmonary disease (COPD) outpatients at Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam. A cross-sectional study was conducted between March and May 2020 at the hospital's outpatient department. Those aged ≥18 years, diagnosed with COPD and undergoing COPD treatment, were eligible. The Hospital Anxiety and Depression Scale was used to measure depression and anxiety. Dyspnea was assessed using the modified Medical Research Council (mMRC) dyspnea scale. Among 392 patients, 381 (97%) participated in the study. The number of patients with depression and anxiety was 33.1% and 21.3%, respectively. Compared to men, women were more likely to experience depression (adjusted odds ratio [aOR] = 2.12, 95% confidence interval [CI] = 1.06–4.24) and anxiety (aOR = 4.11, 95% CI = 1.90–8.87). Those not having caregivers were more likely to experience depression (aOR = 3.03, 95% CI = 1.27–7.20) and anxiety (aOR = 3.47, 95% CI = 1.26–9.60). Having mMRC dyspnea scale ≥2 was associated with higher odds of experiencing depression (aOR = 5.94, 95% CI = 3.63–9.72) and anxiety (aOR = 6.78, 95% CI = 3.48–13.18). Those not adhering to medication treatment (aOR = 2.32, 95% CI = 1.15–4.70) and having comorbidity (aOR = 2.02, 95% CI = 1.10–3.73) were more likely to experience anxiety. Routine screening of COPD patients for depression and anxiety is necessary so that early interventions could be provided.\",\"PeriodicalId\":37393,\"journal\":{\"name\":\"WHO South-East Asia journal of public health\",\"volume\":\"37 1\",\"pages\":\"95 - 100\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"WHO South-East Asia journal of public health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/WHO-SEAJPH.WHO_SEAJPH_149_21\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"WHO South-East Asia journal of public health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/WHO-SEAJPH.WHO_SEAJPH_149_21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
本研究调查了越南胡志明市范玉达医院慢性阻塞性肺疾病(COPD)门诊患者抑郁和焦虑的患病率及其相关因素。2020年3月至5月期间,在医院门诊部进行了一项横断面研究。年龄≥18岁,诊断为COPD并正在接受COPD治疗的患者入选。采用医院焦虑抑郁量表对抑郁和焦虑进行测量。呼吸困难采用改良的医学研究委员会(mMRC)呼吸困难量表进行评估。在392例患者中,381例(97%)参加了研究。抑郁和焦虑患者分别占33.1%和21.3%。与男性相比,女性更容易经历抑郁(调整优势比[aOR] = 2.12, 95%可信区间[CI] = 1.06-4.24)和焦虑(aOR = 4.11, 95% CI = 1.90-8.87)。那些没有照顾者的人更有可能经历抑郁(aOR = 3.03, 95% CI = 1.27-7.20)和焦虑(aOR = 3.47, 95% CI = 1.26-9.60)。mMRC呼吸困难量表≥2与出现抑郁(aOR = 5.94, 95% CI = 3.63-9.72)和焦虑(aOR = 6.78, 95% CI = 3.48-13.18)的几率较高相关。那些不坚持药物治疗(aOR = 2.32, 95% CI = 1.15-4.70)和有合并症(aOR = 2.02, 95% CI = 1.10-3.73)的人更容易感到焦虑。对慢性阻塞性肺病患者进行抑郁和焦虑的常规筛查是必要的,以便提供早期干预措施。
Factors associated with anxiety and depression among chronic obstructive pulmonary disease outpatients in Ho Chi Minh City, Vietnam
This study investigates the prevalence of and associated factors with depression and anxiety among chronic obstructive pulmonary disease (COPD) outpatients at Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam. A cross-sectional study was conducted between March and May 2020 at the hospital's outpatient department. Those aged ≥18 years, diagnosed with COPD and undergoing COPD treatment, were eligible. The Hospital Anxiety and Depression Scale was used to measure depression and anxiety. Dyspnea was assessed using the modified Medical Research Council (mMRC) dyspnea scale. Among 392 patients, 381 (97%) participated in the study. The number of patients with depression and anxiety was 33.1% and 21.3%, respectively. Compared to men, women were more likely to experience depression (adjusted odds ratio [aOR] = 2.12, 95% confidence interval [CI] = 1.06–4.24) and anxiety (aOR = 4.11, 95% CI = 1.90–8.87). Those not having caregivers were more likely to experience depression (aOR = 3.03, 95% CI = 1.27–7.20) and anxiety (aOR = 3.47, 95% CI = 1.26–9.60). Having mMRC dyspnea scale ≥2 was associated with higher odds of experiencing depression (aOR = 5.94, 95% CI = 3.63–9.72) and anxiety (aOR = 6.78, 95% CI = 3.48–13.18). Those not adhering to medication treatment (aOR = 2.32, 95% CI = 1.15–4.70) and having comorbidity (aOR = 2.02, 95% CI = 1.10–3.73) were more likely to experience anxiety. Routine screening of COPD patients for depression and anxiety is necessary so that early interventions could be provided.
期刊介绍:
The journal will cover technical and clinical studies related to health, ethical and social issues in field of Public Health, Epidemiology, primary health care, epidemiology, health administration, health systems, health economics, health promotion, public health nutrition, communicable and non-communicable diseases, maternal and child health, occupational and environmental health, social and preventive medicine. Articles with clinical interest and implications will be given preference.